Skip to main content
. 2005 Mar;91(3):385–387. doi: 10.1136/hrt.2003.026856

Table 1.

 Clinical data of the patient groups

Groups Control (n = 31) CD DCM
0 (n = 43) NYHA I–II (n = 20) NYHA III–IV (n = 27) NYHA I–II (n = 22) NYHA III–IV (n = 25)
Age (years) 54.3 (2.3) 52.0 (1.5) 53.2 (3.1) 48.3 (2.1) 47.0 (3.1) 46.9 (2.5)
Male/Female 16/15 11/32 7/13 15/12 13/9 16/9
SBP (mm Hg) 120.8 (2.0) 123.7 (1.8) 110.6 (2.4)* 97.7 (2.7)* 113.7 (2.6)* 100.8 (3.2)*
DBP (mm Hg) 76.3 (0.9) 78.1 (1.0) 74.4 (1.3) 70.6 (1.5)* 74.8 (1.4) 72.0 (1.6)*
Heart rate (bpm) 74.7 (1.1) 70.1 (1.3) 71.4 (2.2) 73.5 (2.3) 73.4 (2.2) 81.7 (2.4)*
ECG: pacemaker 4 4 5 0 0
Normal/Abnormal 16/23 0/16 0/22 0/22 0/25
Echo: LVEF (%) 68.1 (1.2) 38.3 (2.0)* 26.0 (1.5)* 36.3 (2.3)* 23.7 (1.4)*
LVEF>50%/<50% 43/0 2/18 0/27 1/21 0/25

*Denotes p<0.05 v Chagas group 0.

CD, Chagas’ disease; DBP, diastolic blood pressure; DCM, dilated cardiomyopathy; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; SBP, systolic blood pressure.

Abnormal ECG includes arrhythmias, flutter and atrial fibrillation, any bundle branch block, atrioventricular block, atrial/ventricular hypertrophy.